EMA — authorised 1 August 2001
- Marketing authorisation holder: LINDE HEALTHCARE AB
- Status: approved
EMA authorised Inomax on 1 August 2001
Same drug, different regulators. Each page below lists the local marketing authorisation, HTA position, pricing, and adverse-event data.
Yes. EMA authorised it on 1 August 2001.
LINDE HEALTHCARE AB holds the EU marketing authorisation.